KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma
KSR2-14-3-3ζ 复合物可作为索拉非尼耐药肝细胞癌的生物标志物和潜在治疗靶点
期刊:Biomarker Research
影响因子:9.5
doi:10.1186/s40364-022-00361-9
Chao Gao #, Si-Wei Wang #, Jia-Cheng Lu #, Xiao-Qiang Chai #, Yuan-Cheng Li, Peng-Fei Zhang, Xiao-Yong Huang, Jia-Bin Cai, Yi-Min Zheng, Xiao-Jun Guo, Guo-Ming Shi, Ai-Wu Ke, Jia Fan